香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告的內容概 不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或 任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 上海復旦微電子集團股份有限公司 Shanghai Fudan Microelectronics Group Company Limited* ( 在中華人民共和國註冊成立的股份有限公司 ) (股份編號: 1385) 2025 年第三季度報告 上海復旦微電子集團股份有限公司(「本公司」或「公司」)董事會(「董事會」)欣然宣佈，本公 司及各附屬公司(「本集團」或「集團」)截至 2025 年 9 月 30 日止九個月按照中國企業會計準則 編製的之第三季度未經審計合併業績報告。 本公告乃根據香港法例第 571 章證券及期貨條例第 XIVA 部項下內幕消息條文及香港聯合交易所有限公司證券上市規則第 13.09(2)和第 13.10B 條 的要求而作出。 重要內容提示： 公司董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、準確、完整，不 存在虛假記載、誤導性陳述或重大遺漏，並承擔個別和 ...

Financial Performance - Total revenue for the third quarter of 2025 was RMB 139,249,323.84, representing a decrease of 85.48% compared to the same period last year[11]. - Net profit attributable to shareholders for the quarter was RMB 5,695,374.68, an increase of 57.36% year-over-year[11]. - Basic earnings per share for the quarter was RMB 0.0057, up 56.98% compared to the same period last year[11]. - Net profit attributable to shareholders for the year-to-date period was RMB 2,089,726.41, down 87.27% compared to the same period last year[11]. - Total operating revenue decreased by 76.77% to ¥461,782,507.83 compared to ¥1,987,514,255.44 in the same period last year[21]. - Operating profit decreased by 94.46% to ¥1,064,977.18 from ¥19,221,377.68, primarily due to reduced brokerage income and net interest income[24]. - Total profit dropped by 93.16% to ¥1,487,510.52 from ¥21,756,815.18, mainly due to decreased brokerage income and net interest income[24]. - Net profit decreased by 87.27% to ¥2,089,726.41 from ¥16,419,986.60, reflecting a significant reduction in total profit[25]. - Total comprehensive income for the current period is 200,542.79, a significant decrease from 15,093,914.36 in the previous period[40]. Assets and Liabilities - Total assets at the end of the reporting period were RMB 12,532,567,660.71, reflecting a growth of 7.12% from the previous year[14]. - Total assets of the company as of September 30, 2025, amounted to CNY 12,532,567,660.71, an increase from CNY 11,699,369,620.88 at the beginning of the period, reflecting a growth of approximately 7.1%[34]. - The company's total liabilities increased to CNY 10,200,000,000, with a notable rise in payable margin deposits to CNY 9,925,702,816.22 from CNY 8,812,672,179.43, which is an increase of around 12.6%[35]. - Total liabilities increased from CNY 9,822,590,967.55 to CNY 10,665,666,242.37, representing a growth of 8.6%[36]. - Total equity attributable to shareholders decreased by 0.53% to RMB 1,866,901,418.34[14]. - Total equity attributable to shareholders rose slightly from CNY 1,866,901,418.34 to CNY 1,876,778,653.33, an increase of 0.6%[36]. Cash Flow - Cash flow from operating activities for the year-to-date period decreased by 64.13% to RMB 874,254,026.51[11]. - Cash inflow from operating activities totals 4,353,731,129.04, compared to 5,163,680,068.13 in the previous period, indicating a decline of approximately 15.6%[43]. - Net cash flow from operating activities is 874,254,026.51, down from 2,436,949,452.19, reflecting a decrease of about 64.1%[44]. - Cash inflow from investment activities is 16,284,329,874.91, an increase from 13,442,079,240.90 in the previous period[44]. - Cash inflow from financing activities is 110,721,640.00, significantly higher than 5,000,000.00 in the previous period[45]. - The ending cash and cash equivalents balance is 7,696,230,855.06, up from 6,915,986,078.89 in the previous period[45]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 54,428[26]. - The largest shareholder, Jiangsu Suhao Holding Group Co., Ltd., holds 27.33% of shares, totaling 275,456,777 shares[28]. - The second-largest shareholder, Hong Kong Central Clearing Limited, holds 24.78% of shares, totaling 249,681,239 shares[28]. - The number of shares released from lock-up on August 8, 2025, was 431,642,122 shares, accounting for 42.83% of the total share capital and 56.94% of the A-share capital[32]. - The company has no significant changes in the participation of major shareholders in the securities lending business[29]. - The company has not disclosed any related party transactions or concerted actions among the top shareholders[29]. Other Financial Metrics - The weighted average return on net assets for the quarter was 0.31%, an increase of 60.71% year-over-year[11]. - The company reported a net profit excluding non-recurring gains and losses of RMB 5,519,223.26, up 74.57% year-over-year[11]. - Other comprehensive income after tax decreased by 42.46% to -¥1,889,183.62, mainly due to foreign exchange fluctuations[25]. - Comprehensive income total decreased by 98.67% to ¥200,542.79 from ¥15,093,914.36, primarily due to the reduction in net profit[25]. - The company’s long-term equity investments slightly increased to CNY 8,768,835.07 from CNY 8,709,774.28, showing a marginal growth[35]. - The derivative financial liabilities rose to CNY 37,170,223.03 from CNY 9,859,658.01, indicating a significant increase in financial obligations[35]. - The company has approved a cash dividend distribution plan for the fiscal year 2024, with dividends to be distributed on August 8, 2025[30]. Operational Changes - The company did not report any significant new product developments or market expansion strategies during the quarter[11]. - The company has not undergone an audit for the third quarter financial report[46].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 （於中華人民共和國註冊成立之股份有限公司） （股份代號：1772） 內 幕 消 息╱海 外 監 管 公 告 2025年第三季度報告 本 公 告 乃 根 據《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》（「上市規則」） 第13.09(2)條及第13.10B條 的 披 露 義 務 及 證 券 及 期 貨 條 例（香 港 法 例 第 571章）第XIVA部 項 下 的 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 重 要 內 容 提 示： 是 ✓ 否 – 1 – 1. 江 西 贛 鋒 鋰 業 集 團 股 份 有 限 公 司（「公 司」或「本公司」）董 事 會（「董 事 會」）、監 事 會 及 其 董 事、監 事、高 級 管 理 人 員 保 證 截 至2025年9月30 日 止3個 月（「本報告期」） ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因依賴 該等內容而引致之任何損失承擔任何責任。 Pharmaron Beijing Co., Ltd. 康 龍 化 成（ 北 京 ）新 藥 技 術 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3759） 2025年第三季度報告 本公告乃由康龍化成（北京）新藥技術股份有限公司（「本公司」，連同其附屬公司 「本集團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及 第13.10B條以及證券及期貨條例（香港法例第571章）第XIVA部項下的內幕消息條 文（定義見上市規則）而作出。 以下為本公司的2025年第三季度報告。除本報告第四節第三部分按照國際會計準 則理事會頒佈的國際財務報告準則（「國際財務報告準則」）編製或另有註釋外，本 2025年第三季度報告所載之財務數據根據中國企業會計準則編製且未經審計。 1 康龍化成（北京）新藥技術股份有限公司 Pharmaron Beijing Co., Ltd. ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔 任 何 責 任。 00991 海外監管及內幕消息公告 2025 年第三季度報告 根 據 中 國 證 券 監 督 管 理 委 員 會 的 規 定，大 唐 國 際 發 電 股 份 有 限 公 司（「本 公 司」或「公 司」）需 於 第 一 季 度 和 第 三 季 度 刊 發 季 度 報 告。本 季 度 報 告 內 所 載 的 財 務 數 據 均 未 經 審 計，並 根 據 中 國 企 業 會 計 準 則 而 編 製。本 公 告 乃 為 本 公 司 根 據 證 券 及 期 貨 條 例（香 港 法 例 第 571 章）第 XIVA 部下之內幕消息條文 （根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」）下 所 定 義）及 上 市規則第 13.09(2)(a) 及 13.10B 條 的 規 定 所 發 出。 重 要 內 容 提 示： ...

Financial Performance - Total revenue for the six months ended August 31, 2025, was HKD 11,993,000, a significant decrease of 87.2% compared to HKD 93,704,000 for the same period in 2024[3] - The company reported a profit of HKD 18,279,000 for the current period, compared to a loss of HKD 22,889,000 in the previous year, indicating a turnaround in performance[3] - Basic and diluted earnings per share for the current period were HKD 30.47, compared to a loss per share of HKD 47.16 in the previous year[4] - For the six months ended August 31, 2025, the total revenue was HKD 11,993,000, a significant decrease from HKD 93,704,000 in the same period of 2024, representing a decline of approximately 87.2%[19] - Total revenue for the group was approximately HKD 12.0 million, a decrease of about 87.2% compared to the same period last year[67] - The group recorded a profit and total comprehensive income of approximately HKD 18.3 million, compared to a loss of approximately HKD 22.9 million in the same period last year[91] Revenue Breakdown - Revenue from corporate finance advisory services increased to HKD 4,815,000 from HKD 4,347,000, reflecting a growth of 10.8%[4] - The income from corporate finance advisory services increased to HKD 4,815,000 in 2025 from HKD 4,347,000 in 2024, reflecting a growth of about 10.8%[19] - Revenue from securities trading and brokerage services rose to HKD 2,581,000, up from HKD 1,270,000, marking a growth of 103%[4] - The commission income from securities trading and brokerage services rose to HKD 2,581,000 in 2025, compared to HKD 1,270,000 in 2024, marking an increase of approximately 103%[19] - The group’s asset management business saw revenue increase by approximately 485.4% compared to the same period last year[67] - The total revenue from securities trading and brokerage services was HKD 32,633,000 for the six months ended August 31, 2025, up from HKD 29,487,000 in 2024[38] Assets and Liabilities - Total assets as of August 31, 2025, amounted to HKD 356,553,000, compared to HKD 353,027,000 as of February 28, 2025, showing a slight increase[5] - Current assets totaled HKD 354,079,000, a marginal increase from HKD 350,483,000 as of February 28, 2025[5] - The company’s net current assets increased to HKD 202,933,000 from HKD 184,578,000, indicating improved liquidity[6] - The total equity of the company as of August 31, 2025, was HKD 205,152,000, up from HKD 186,873,000 as of February 28, 2025[6] - The company’s total liabilities included a provision for credit losses of HKD 183,000 for the six months ended August 31, 2025, compared to HKD 105,000 in 2024[38] - As of August 31, 2025, the total receivables amounted to HKD 32,647,000, an increase from HKD 29,797,000 as of February 28, 2025, representing a growth of approximately 9.3%[20] Operational Highlights - The company continues to focus on expanding its financial services, including corporate finance advisory and asset management services, to enhance revenue streams[7] - The group participated in 6 IPO sponsorship projects during the period, up from 4 projects in the same period last year, generating revenue of approximately HKD 1.5 million[72] - The group participated in 16 financial advisory projects this period, generating revenue of approximately HKD 2.5 million, down from HKD 3.0 million in the same period last year[73] - The group engaged in 7 compliance advisory projects, with revenue of about HKD 0.8 million, compared to HKD 1.0 million last year[74] - The group completed 4 placement and underwriting projects, resulting in revenue of approximately HKD 1.4 million, a significant decrease from HKD 85.7 million in the previous year[76] Employee and Operational Costs - Employee costs for the six months ended August 31, 2025, totaled HKD 11,798,000, an increase from HKD 10,837,000 in 2024, reflecting a rise in salaries and allowances[26] - Other operating expenses decreased by approximately 92.0% to about HKD 7.1 million, primarily due to the absence of bond underwriting activities this period[89] - Employee costs increased by approximately 8.9% to about HKD 11.8 million, attributed to an increase in the number of professionals compared to the same period last year[90] Strategic Initiatives - The company plans to sell equity stakes in two unlisted companies at an appropriate time, having acquired shares in these companies for a total of approximately HKD 5,855,000[44] - The group plans to enhance its core business by expanding product offerings, improving service content, and broadening its customer base[109] - The group is actively exploring strategic opportunities for business diversification to drive long-term growth[109] - The group maintains a cautiously constructive outlook on global financial markets, acknowledging emerging opportunities while being aware of ongoing risks[107] Governance and Compliance - The audit committee has reviewed the group's unaudited condensed consolidated financial statements for the period[115] - The group has complied with the corporate governance code throughout the reporting period[112] - The company has confirmed that there are no competing businesses or conflicts of interest among directors and major shareholders as of the announcement date[119] - The company will issue its interim performance announcement and report, which includes all information required by listing rules, to shareholders and publish it on the Hong Kong Stock Exchange website and its own website[133]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 CHALIECO 中鋁國際工程股份有限公司 China Aluminum International Engineering Corporation Limited （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2068） 公 告 本公司截至二零二五年九月三十日止的 第三季度季度報告 本公告是根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2) 條及香港法例第571章證券及期貨條例第XIVA部 項 下 內 幕 信 息 條 文 而 做 出。 本公告隨附的經營業績為中鋁國際工程股份有限公司（「本公司」或「公 司」）於 上 海證券交易所（網 站：www.sse.com.cn）網站披露的本公司根據中國企業會計準則 編 製、未 經 審 核 的 截 至 二 零 二 五 年 九 月 三 十 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Bank of Qingdao Co., Ltd.* 青 島 銀 行 股 份 有 限 公 司 * （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （H股股份代號：3866） 2025年第三季度報告 青島銀行股份有限公司（「本行」）根據《香港聯合交易所有限公司證券上市規則》（「上市規 則」）第13.09條及香港法例第571章《證券及期貨條例》第XIVA部項下之內幕消息條文（按 上市規則定義）作出本公告。 本報告以中英文編製，如中英文文本有任何不一致，以中文文本為準。 重要內容提示： - 1 - 1. 本行董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、準 確、完整，不存在虛假記載、誤導性陳述或者重大遺漏，並承擔個別和連帶的法律 責任。 2. 本行第九屆董事會（「董事會」）第二十次會議於2025年10月28日以通訊表決方式召 開，會議應參與表決董事14名， ...

Financial Performance - Total revenue for the first nine months of 2025 was CNY 120.80 billion, a decrease from CNY 144.02 billion in the same period of 2024, representing a decline of approximately 16.1%[12] - Net profit for the first nine months of 2025 was CNY 4.48 billion, down from CNY 10.29 billion in 2024, reflecting a decrease of about 56.5%[12] - Operating profit decreased to CNY 7.57 billion in 2025 from CNY 15.22 billion in 2024, a decline of approximately 50.3%[12] - Total comprehensive income for the first nine months of 2025 was CNY 4.81 billion, compared to CNY 11.89 billion in 2024, a decline of about 59.5%[16] - Operating profit for the first nine months of 2025 was RMB 1.04 billion, down from RMB 3.00 billion in 2024, indicating a decline of about 65.4%[32] - Net profit for the first nine months of 2025 was RMB 1.03 billion, compared to RMB 3.01 billion in 2024, reflecting a decrease of approximately 65.7%[32] Assets and Liabilities - As of September 30, 2025, the total assets of BAIC Motor Corporation amounted to RMB 161.83 billion, a decrease from RMB 172.04 billion as of December 31, 2024[5] - The company's current assets totaled RMB 73.00 billion, down from RMB 81.69 billion in the previous audited period[5] - The total liabilities decreased to RMB 82.61 billion from RMB 93.56 billion, indicating a reduction in financial obligations[8] - Total assets as of September 30, 2025, amounted to RMB 105.11 billion, up from RMB 101.15 billion at the end of 2024, marking an increase of about 3.9%[24] - Current assets totaled RMB 40.32 billion as of September 30, 2025, compared to RMB 37.61 billion at the end of 2024, representing a growth of approximately 7.2%[24] - Total liabilities increased to RMB 23.28 billion as of September 30, 2025, from RMB 20.39 billion at the end of 2024, indicating a rise of about 14.5%[27] Cash Flow and Equivalents - The company's cash and cash equivalents were RMB 26.30 billion, compared to RMB 34.64 billion at the end of 2024, reflecting a significant decline[5] - Cash flow from operating activities for the first nine months of 2025 was CNY 2.40 billion, significantly lower than CNY 18.06 billion in 2024, a decrease of approximately 86.7%[19] - Cash and cash equivalents at the end of September 2025 were CNY 24.78 billion, down from CNY 34.46 billion at the end of September 2024, a decrease of approximately 28.2%[22] - Cash and cash equivalents decreased to RMB 2.66 billion as of September 30, 2025, from RMB 5.26 billion at the end of 2024, a decline of approximately 49.5%[24] - The company reported a net decrease in cash and cash equivalents of ¥3,128,095,985.73, compared to a decrease of ¥4,010,228,169.90 in the previous period[38] - The ending balance of cash and cash equivalents was ¥2,132,536,558.46, down from ¥5,260,632,544.19 at the beginning of the period[38] Shareholder Equity - The total equity attributable to shareholders rose slightly to RMB 57.58 billion from RMB 57.31 billion, showing a modest increase in shareholder value[8] - The total equity of the company as of September 30, 2025, was RMB 81.83 billion, an increase from RMB 80.76 billion at the end of 2024, representing a growth of approximately 1.3%[27] Expenses - Research and development expenses were CNY 1.05 billion in 2025, slightly down from CNY 1.08 billion in 2024, indicating a decrease of about 2.0%[12] - The company incurred sales expenses of CNY 5.83 billion in 2025, down from CNY 8.33 billion in 2024, a decrease of approximately 30.1%[12] - The company’s financial expenses decreased to CNY 274.04 million in 2025 from CNY 388.33 million in 2024, reflecting a reduction of about 29.3%[12] - Research and development expenses for the first nine months of 2025 were RMB 244.02 million, significantly higher than RMB 52.75 million in 2024, reflecting an increase of about 362.5%[32] Investment and Future Plans - The company has indicated plans for market expansion and new product development, although specific figures were not disclosed in the current report[3] - The company reported an investment loss of CNY 183.44 million in 2025, compared to a loss of CNY 450.25 million in 2024, showing an improvement of about 59.3%[12]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 2025年第三季度報告 1 一、釋義 本公司、公司、一拖股份 指 第一拖拉機股份有限公司 2 中國一拖 指 中國一拖集團有限公司（本公司控股股東） 中國證監會 指 中國證券監督管理委員會 聯交所 指 香港聯合交易所有限公司 A股 指 經中國證監會批准向境內投資者及合資格境外投 資者發行、在中國境內證券交易所上市、以人民 幣標明股票面值、以人民幣認購和進行交易的普 通股 H股 指 經中國證監會批准向境外投資者發行、經聯交所 批准上市、以人民幣標明股票面值、以港幣認購 和進行交易的普通股 重要內容提示： 公司董事會（「董事會」）及其董事、高級管理人員保證季度報告內容的真實、準確、完 整，不存在虛假記載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責任。 公司負責人、主管會計工作負責人及會計機構負責人（會計主管人員）保證季度報告 中財務信息的真實、準確、完整。 第三季度財務報表未經審計。 二、主要財務數據 （ ...